Acumen Pharmaceuticals Inc
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
ABOS Income Statement
|Total revenues||2 M||0||0|
|Cost of sales||0||0||-159000|
|Gross operating profit||2 M||0||0|
|Selling Gen & administrative expense||926000||-85000||7 M|
|Research & development expense||9 M||8 M||12 M|
|Operating income||-8 M||-8 M||-20 M|
|Other income net||-147000||586000||-81 M|
|Pre-tax Income (EBT)||-8 M||-7 M||-101 M|
|Net income from total operations||-8 M||-7 M||-101 M|
|Total net income||-8 M||-7 M||-101 M|
|Net income available for common||-8 M||-7 M||-101 M|
|Operating income before depreciation (EBITDA)||-8 M||-8 M||-20 M|
|Total Income available for floaterest expense (EBIT)||0||0||0|
|Basic EPS total||-0.27||-0.28||-5.02|
|Diluted EPS total||-0.27||-0.28||-5.02|
Sanderson Farms Inc.
Rush Enterprises Inc. Class B Common Stock
Gaming and Leisure Properties Inc.
General Mills Inc.
National Retail Properties
Oppenheimer Holdings Inc. Class A (DE)
Kronos Worldwide Inc
BJ's Wholesale Club Holdings Inc.
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to email@example.com to avail the extention
From all of us at MarketXLS, thank you!